Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Retraxil

K-Number: K243910 · 2025-09-24

ApplicantKulzer, LLC
Decision Date2025-09-24
Product CodeMVL
DecisionSubstantially Equivalent

Device Summary

Retraxil is a medical device manufactured by Kulzer, LLC. It received FDA 510(k) clearance on 2025-09-24 under approval number K243910. The device is classified under product code MVL. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Retraxil?

Retraxil is a medical device that received FDA 510(k) clearance on 2025-09-24. It is manufactured by Kulzer, LLC. The 510(k) number is K243910.

When was Retraxil approved by the FDA?

Retraxil received FDA 510(k) clearance on 2025-09-24, under approval number K243910.

What company makes Retraxil?

Retraxil is manufactured by Kulzer, LLC.

What is the FDA product code for Retraxil?

The FDA product code for Retraxil is MVL.

Other Devices by Kulzer, LLC

View all 7 devices →

Related Devices (Code: MVL)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.